Literature DB >> 11331209

A nuclear receptor in thyroid malignancy: is PAX8/PPARgamma the Holy Grail of follicular thyroid cancer?

D Fuhrer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331209     DOI: 10.1530/eje.0.1440453

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


× No keyword cloud information.
  1 in total

1.  The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer.

Authors:  Tianbing Fan; Wenbo Zhu; Min Kong; Xiaochan Yang; Cheng Wang; Min Wang; Zhaoyin Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-06-23       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.